Literature DB >> 27128498

Drosophila melanogaster as a suitable in vivo model to determine potential side effects of nanomaterials: A review.

Mohamed Alaraby1,2, Balasubramanyam Annangi1, Ricard Marcos1,3, Alba Hernández1,3.   

Abstract

Despite being a relatively new field, nanoscience has been in the forefront among many scientific areas. Nanoparticle materials (NM) present interesting physicochemical characteristics not necessarily found in their bulky forms, and alterations in their size or coating markedly modify their physical, chemical, and biological properties. Due to these novel properties there is a general trend to exploit these NM in several fields of science, particularly in medicine and industry. The increased presence of NM in the environment warrants evaluation of potential harmful effects in order to protect both environment and human exposed populations. Although in vitro approaches are commonly used to determine potential adverse effects of NM, in vivo studies generate data expected to be more relevant for risk assessment. As an in vivo model Drosophila melanogaster was previously found to possess reliable utility in determining the biological effects of NM, and thus its usage increased markedly over the last few years. The aims of this review are to present a comprehensive overview of all apparent studies carried out with NM and Drosophila, to attain a clear and comprehensive picture of the potential risk of NM exposure to health, and to demonstrate the advantages of using Drosophila in nanotoxicological investigations.

Entities:  

Mesh:

Year:  2016        PMID: 27128498     DOI: 10.1080/10937404.2016.1166466

Source DB:  PubMed          Journal:  J Toxicol Environ Health B Crit Rev        ISSN: 1093-7404            Impact factor:   6.393


  8 in total

Review 1.  Engineered nanomaterial-induced lysosomal membrane permeabilization and anti-cathepsin agents.

Authors:  Melisa Bunderson-Schelvan; Andrij Holian; Raymond F Hamilton
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017       Impact factor: 6.393

2.  Drosophila as a Suitable In Vivo Model in the Safety Assessment of Nanomaterials.

Authors:  Eşref Demir; Fatma Turna Demir; Ricard Marcos
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Comparison of silver nanoparticle-induced inflammatory responses between healthy and metabolic syndrome mouse models.

Authors:  Lisa Kobos; Saeed Alqahtani; Li Xia; Vincent Coltellino; Riley Kishman; Daniel McIlrath; Carlos Perez-Torres; Jonathan Shannahan
Journal:  J Toxicol Environ Health A       Date:  2020-04-12

4.  Publication trends of somatic mutation and recombination tests research: a bibliometric analysis (1984‒2020).

Authors:  Ghada Tagorti; Bülent Kaya
Journal:  Genomics Inform       Date:  2022-03-31

5.  Zinc Detoxification: A Functional Genomics and Transcriptomics Analysis in Drosophila melanogaster Cultured Cells.

Authors:  Stephanie E Mohr; Kirstin Rudd; Yanhui Hu; Wei Roc Song; Quentin Gilly; Michael Buckner; Benjamin E Housden; Colleen Kelley; Jonathan Zirin; Rong Tao; Gabriel Amador; Katarzyna Sierzputowska; Aram Comjean; Norbert Perrimon
Journal:  G3 (Bethesda)       Date:  2018-02-02       Impact factor: 3.154

6.  The effects of a human food additive, titanium dioxide nanoparticles E171, on Drosophila melanogaster - a 20 generation dietary exposure experiment.

Authors:  Boris Jovanović; Nikola Jovanović; Vladimir J Cvetković; Sanja Matić; Snežana Stanić; Elizabeth M Whitley; Tatjana Lj Mitrović
Journal:  Sci Rep       Date:  2018-12-18       Impact factor: 4.379

7.  Genotoxicity of Copper and Nickel Nanoparticles in Somatic Cells of Drosophila melanogaster.

Authors:  Erico R Carmona; Alba García-Rodríguez; Ricard Marcos
Journal:  J Toxicol       Date:  2018-07-19

8.  Enteric pH responsive cargo release from PDA and PEG coated mesoporous silica nanoparticles: a comparative study in Drosophila melanogaster.

Authors:  Nidhi Sapre; Rusha Chakraborty; Poorvi Purohit; Suresh Bhat; Gaurav Das; Sneha R Bajpe
Journal:  RSC Adv       Date:  2020-03-23       Impact factor: 4.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.